(AmericanProsperity.com) – Late Sunday evening, the Food and Drug Administration (FDA) issued a limited emergency-use authorization of two malaria drugs to aid in the fight against COVID-19. The drugs are not a solution to the coronavirus as there is no proven treatment or cure. However, the drugs will help alleviate symptoms for patients until a vaccine is developed.
In a statement on Sunday night, the Health and Human Services Department (HHS) announced it received 30 million doses of hydroxychloroquine sulfate and one million doses of chloroquine phosphate. The drugs were a donation from the Strategic National Stockpile.
.@POTUS’s leadership and the hard work of @US_FDA and @PHEgov have succeeded in securing large donations of medicine: 30 million doses of hydroxychloroquine sulfate donated by Sandoz and 1 million doses of chloroquine phosphate donated by Bayer. https://t.co/4KPYHdTfY6
— Secretary Alex Azar (@SecAzar) March 30, 2020
These oral prescription drugs are primarily used to prevent and treat malaria.
The FDA’s emergency authorization allows doctors to only prescribe the medication to teen and adult patients with COVID-19 because a clinical trial is not yet available. On Monday morning, it was announced that Johnson & Johnson signed a $450-million coronavirus contract with the federal government to develop a vaccine. Human trials are expected to start in September.
~Here’s to Your Prosperity!
Copyright 2020, AmericanProsperity.com